![HEART FAILURE BWGHF on X: "Great news: ESC Guidelines on heart failure management launched today. #ESCCongress2021 #heartfailure #guidelines #esc #hfa #HFrEF #HFpEF #HFmrEF https://t.co/6r3288KsLP https://t.co/RPJM57VNB3" / X HEART FAILURE BWGHF on X: "Great news: ESC Guidelines on heart failure management launched today. #ESCCongress2021 #heartfailure #guidelines #esc #hfa #HFrEF #HFpEF #HFmrEF https://t.co/6r3288KsLP https://t.co/RPJM57VNB3" / X](https://pbs.twimg.com/media/E9yX3gXXEAIAzil.jpg)
HEART FAILURE BWGHF on X: "Great news: ESC Guidelines on heart failure management launched today. #ESCCongress2021 #heartfailure #guidelines #esc #hfa #HFrEF #HFpEF #HFmrEF https://t.co/6r3288KsLP https://t.co/RPJM57VNB3" / X
![ELSO on X: "2019 ESC guidelines for diagnosis & management of acute pulmonary embolism developed in collaboration with ERS. Temporary use of #MCS mostly VA #ECMO may be considered, & may be ELSO on X: "2019 ESC guidelines for diagnosis & management of acute pulmonary embolism developed in collaboration with ERS. Temporary use of #MCS mostly VA #ECMO may be considered, & may be](https://pbs.twimg.com/media/EDovhBhWkAAT-V0.jpg:large)
ELSO on X: "2019 ESC guidelines for diagnosis & management of acute pulmonary embolism developed in collaboration with ERS. Temporary use of #MCS mostly VA #ECMO may be considered, & may be
Findings from iCCM Evidence Symposium (Diaz et al. JOGH 2014) - Nairobi iCCM Meeting 2016 | Child Health Task Force
![Task Force II: Indirect and Secondary Cardiovascular Effects of Biological Terrorism Agents and Diseases | Journal of the American College of Cardiology Task Force II: Indirect and Secondary Cardiovascular Effects of Biological Terrorism Agents and Diseases | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/684383f5-ba67-49be-9811-1269b7b4b0c6/j.jacc.2007.01.020.fp.png)
Task Force II: Indirect and Secondary Cardiovascular Effects of Biological Terrorism Agents and Diseases | Journal of the American College of Cardiology
![Plasma PAI-1 antigen concentration predicts clinical outcome of thrombolytic treatment of acute myocardial infarction | Journal of the American College of Cardiology Plasma PAI-1 antigen concentration predicts clinical outcome of thrombolytic treatment of acute myocardial infarction | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/b62a3dd0-80f1-4b5c-bcbb-0d2633a5a04e/s0735-1097(03)81661-3.fp.png)